TLR4 and ischemic stroke: The antitumor activity and acute myeloid leukocyte drug methylisoindigo attenuated ischemic stroke-induced brain injury by blocking the activation of NLRP3 inflammatory vesicles and modulating microglia/macrophage polarization through inhibition of the TLR4/NF-κB signaling pathway [187].